Researchers sought to determine whether patients with ALL receiving E. coli-derived asparaginase who develop hypersensitivity should switch to a non-E. coli-derived asparaginase.
Researchers sought to determine whether the VpreB1 subunit of the immunoglobulin heavy chain surrogate light chain may be a therapeutic target in patients with ALL.
Researchers sought to determine whether the presence of anti-murine CD19-targeted chimeric antigen receptor antibodies would affect tisagenlecleucel activity.
Researchers sought to assess the survival for adult patients with relapsed Ph-positive ALL after allo-HCT over 20 years.
Researchers sought to determine whether deregulation of valine transfer RNA would be part of the pathogenesis of T cell acute lymphoblastic leukemia.
Researchers sought to determine whether silencing of microRNAs associated with ALL would have antileukemic effects in leukemic cell lines.
Researchers sought to determine the incidence of bleeding and thrombotic events in patients receiving CAR-T therapy.
Researchers sought to determine whether T cell replete HLA haploidentical hematopoietic stem cell transplantation with low-dose anti-thymocyte globulin would improve outcomes in patients with BCP-ALL.
Researchers sought to determine risks associated with miRNA-181a in patients with ALL.
Researchers sought to determine whether a low dose of inotuzumab ozogamicin would be safe and effective in patients with relapsed/refractory ALL.
